N, T., A, G., B, K., K, K., E, A., & A, P. (2025). The new thiazolidine-2,4-dione-based hybrids with promising antimycobacterial activity: Design, synthesis, biological evaluation, and drug interaction analysis. Journal of enzyme inhibition and medicinal chemistry, 40(1), 2442703. https://doi.org/10.1080/14756366.2024.2442703
Chicago Style (17th ed.) CitationN, Trotsko, Głogowska A, Kaproń B, Kozieł K, Augustynowicz-Kopeć E, and Paneth A. "The New Thiazolidine-2,4-dione-based Hybrids with Promising Antimycobacterial Activity: Design, Synthesis, Biological Evaluation, and Drug Interaction Analysis." Journal of Enzyme Inhibition and Medicinal Chemistry 40, no. 1 (2025): 2442703. https://doi.org/10.1080/14756366.2024.2442703.
MLA (9th ed.) CitationN, Trotsko, et al. "The New Thiazolidine-2,4-dione-based Hybrids with Promising Antimycobacterial Activity: Design, Synthesis, Biological Evaluation, and Drug Interaction Analysis." Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 40, no. 1, 2025, p. 2442703, https://doi.org/10.1080/14756366.2024.2442703.